Answers are grounded in this paper and cite their sources.
Mycosis fungoides is the most common of cutaneous T-cell lymphomas, until now the best treatment has not been defined, probably because actual treatments are palliative, and when the tumor is refractory/ relapse , response and outcomes are poor 'Thus we developed an regimen with gemcitabine- based combined chemotherapy, two drugs with proven efficacy in T-cell lymphomas , and dexamethasone, if the patient achieved complete response , they were allocated in an proportion 1:1, to received thalidomide in 21 of 28 days cycles by 3 years One hundred and twenty-six patients recruit ,122 (88%) achieved complete and were allocate to received thalidomide or control group.
No takes yet. Share an insight, caveat, or question.
Agustin Avilés (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: